Target intelligence / Profile preview

Vesicle-trafficking protein SEC22a (SEC22A)

Target
SEC22A
Molecular classification
SNARE protein, Vesicle-trafficking protein, Integral membrane protein, Other (not GPCR, ion channel, enzyme, transporter, or receptor)
01

Overview

Vesicle-trafficking protein SEC22a (SEC22A) is a SNARE protein that facilitates the transport of vesicles between the ER and Golgi, an essential process for protein sorting, secretion, and cellular homeostasis[1][2][4][5]. SEC22A forms part of the multiprotein SNARE complex, promoting membrane fusion events both in the secretory pathway and in autophagic processes[1]. Its functions ensure the correct trafficking and localization of newly synthesized proteins within the cell. Mutations or dysfunctions in SEC22A or its homologs can result in diseases such as neurodegeneration (e.g., Alzheimer's disease), Warburg Micro syndrome, and atherosclerosis, largely due to impaired protein and lipid transport mechanisms[1][5]. Although critical for cell physiology, SEC22A is not a direct pharmacological target but may be of interest in studies of membrane trafficking, cell biology, and certain rare genetic disorders.

Other names
SEC22ASEC22 homolog ASEC22L2SEC22 vesicle-trafficking protein homolog ASEC22 vesicle-trafficking protein-like 2
02

Biological functions

Vesicle trafficking between ER and GolgiSNARE-mediated membrane fusionRegulation of protein secretion and sortingInvolvement in autophagy, unconventional protein secretion, and higher-order membrane fusion complexes
03

Disease associations

Potential roles in neurological disorders (Alzheimer’s disease, Warburg Micro syndrome 1)Associated with atherosclerosis via vesicle transport involvementOther (developmental, cellular morphology roles in model organisms)

Beyond the preview

Go deeper on Vesicle-trafficking protein SEC22a (SEC22A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vesicle-trafficking protein SEC22a (SEC22A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call